CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
The development of oncolytic viruses has led to an emerging new class of cancer therapeutics. Although the safety profile has been encouraging, the transition of oncolytic viruses to the clinical setting has been a slow process due to modifications. Therefore, a new generation of more potent oncolyt...
| 主要な著者: | , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
MDPI AG
2016-03-01
|
| シリーズ: | Viruses |
| 主題: | |
| オンライン･アクセス: | http://www.mdpi.com/1999-4915/8/3/72 |